arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

RxSight, Inc.

RXST

$4.87 ▼ -0.07 (-1.42%) at close

6 Visible periods

31 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

RxSight, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $198.9M

Dividend Yield —

Revenue Growth -3.9% ↘

Op. Margin -35.8% ↘

ROIC -17.5% ↘

FCF / Share $-0.47 ↗

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

6-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$134.48M

↓ -3.9% —

Net Income Profit after all expenses

$-38.94M

↓ -41.8% —

Operating Margin Operating profit as % of sales

-35.8%

↓ -36.0% 7th

FCF / Share Free cash flow per share

$-0.47

↑ +17.8% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Financial Health ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-3.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-178%)	57.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1042%)	81.8% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1535%)	116.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2238%)	53.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+978%)	—
EPS Growth YoY (%)	-33.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	49.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	41.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—
Net Income Growth YoY (%)	-41.8% Weak ↓ Weak Declining Year-over-year change in net income	43.5% Excellent ↑ Excellent Improving Year-over-year change in net income	27.2% Excellent Excellent Year-over-year change in net income	-37.1% Weak Weak Year-over-year change in net income	N/M	—
FCF Growth YoY (%)	17.8% Good ↓ Good Declining Year-over-year change in free cash flow	57.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	39.2% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	35.3% Excellent Excellent Year-over-year change in free cash flow	66.4% Excellent Excellent Year-over-year change in free cash flow	—
Revenue CAGR 3Y (%)	40.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	83.6% Excellent Excellent Compound annual revenue growth over 3 years	82.4% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—
Revenue CAGR 5Y (%)	55.7% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-35.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-399%)	-26.3% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-320%)	-56.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-569%)	-129.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1177%)	-233.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2047%)	-241.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2110%)
Effective Tax Rate (%) (%)	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%
Profit Margin (%) (%)	-29.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-462%)	-19.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-345%)	-54.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-782%)	-136.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1803%)	-215.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2794%)	—
FCF Margin (%) (%)	-14.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-16.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-52.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-125.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-206.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-257.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%
FCF / Net Income (x)	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-1.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-17.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-48.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	8.7% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%
Return on Capital (%) (%)	-15.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-42.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	-35.2% Weak Weak Operating profit relative to total assets Optimal: > 10%
Return on Common Equity (%) (%)	-14.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-30.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-302%)	-74.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-595%)	-35.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-6.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-143%)

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Debt to Equity (x)	—	—	0.00x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	0.45x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-36%)	0.29x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-59%)	-0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-108%)
Interest Coverage (x)	-2536.37x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1755.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.14x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-12.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-14.34x Weak Weak Operating income divided by interest expense Optimal: > 5x	-69.44x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-19.95M	$-16.71M	$-9.69M	$28.34M	$15.40M	$10.40M
Debt / EBITDA (x)	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.68x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.81x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.77x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$3.29	$3.60	$2.59	$1.77	$1.66	$3.96
Basic EPS, GAAP (USD)	$-0.95	$-0.71	$-1.41	$-2.41	$-3.57	$0.91
Free Cash Flow per Share (USD)	$-0.47	$-0.58	$-1.35	$-2.21	$-3.42	$-10.18
Book Value per Share (USD)	$6.68	$6.96	$4.44	$3.18	$5.05	$-116.15
Tangible Book Value per Share (USD)	$6.68	$6.96	$4.44	$3.18	$5.05	$-116.15
Basic Weighted Avg Shares (shares)	40.85M	38.87M	34.46M	27.66M	13.63M	3.71M

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$261.21M	$267.95M	$147.50M	$117.32M	$165.22M	$69.90M
LT Debt (USD)	—	—	$0.00	$40.17M	$39.76M	$24.40M
Total Equity (USD)	$275.68M	$281.24M	$160.36M	$89.90M	$138.24M	$-430.59M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$134.48M	$139.93M	$89.08M	$49.01M	$22.59M	$14.68M
Depreciation Expense (USD)	$3.27M	$3.58M	$4.08M	$3.88M	$3.98M	$3.85M
Net Income, GAAP (USD)	$-38.94M	$-27.45M	$-48.61M	$-66.76M	$-48.69M	$27.57M
Operating Cash Flow (USD)	$-15.51M	$-16.95M	$-41.59M	$-58.85M	$-44.71M	$-35.20M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 25 quarters

RxSight, Inc.

Analytical Summary

6-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare RXST with peers